SELLAS Life Sciences Group, Inc. Common Stock

SLS XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.5B

Short interest (May 15)

30.7%

Net Short (Jun 03 ): 0.3%

Borrow Fee

14.56%

↑ 70.8%

Available Shares

300K

↓ 49.6%

Price Chart

Company Overview

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001390478

Asset Type: CS

Market Data

Market Cap: $1,549,651,341

Employees: 13

Status: Active

Short Interest

Current Borrow Fee 14.56%

Range: 14.56% - 19.64%

Available Shares 300K

Range: 100K - 450K

Recent Changes

Fee Change: ↓ 25.4%

Available Change: ↑ 155.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime